We provide innovative and affordable healthcare solutions, which promise to level the playing field for millions worldwide
A patented adjustable, minimally invasive intervention to replace Pulmonary Artery Banding
The Problem
Cardiovascular Disease (CVD) is the leading cause of death worldwide
#1 CAUSE OF DEATH
31% of global deaths are a result of CVD
AFFORDABILITY
Low and middle income countries now experience the highest prevalence and mortality rates of CVDs
SCALE
31% of global deaths are a result of CVD
EFFECT
One person dies every 36 seconds in the US from CVD
34 million
$30 billion
Our Solution
Patented, safer and affordable solutions that reduce the risk of cardiovascular treatment
FIRST-OF-ITS-KIND
Adjustable, minimally invasive percutaneous intervention, to replace surgical Pulmonary Artery Banding (PAB)
APPLICATION
We can treat more than 10 cardio-vascular diseases using the HeartPoint Global Implant System (HPGS)
MINIMALLY INVASIVE
Solutions for both juvenile and adult congenital heart defect patients and congestive heart disease patients
RECOVERY
Excessive pulmonary artery blood flow is reduced and the normal function of the heart-lung system is partially or fully restored
Patented, safer and affordable solutions that de-risk cardiovascular treatment
1
ADJUSTABLE
HPGS allows adjustments of pressure up and/or down during or after the initial intervention to improve the structural flow of the heart-lung system.
2
SAFER
HPGS dramatically reduces mortality risk, complication risk, and the suffering associated with surgeries or transplants.
3
MINIMALLY-INVASIVE
HPGS dramatically reduces recovery times and potential complications during and after the procedure.
4
QUALITY-OF-LIFE
HPGS delivers improvements by 2 levels in cardiac function based upon the NYC Heart Association scale.
5
10+ INDICATIONS
HPGS continuously expands the spectrum of heart diseases it can treat.
The first and only minimally invasive adjustable structural heart system that brings affordability, accessibility, and the potential to save millions of lives in the developed and developing world
0 million
Total Available Market0 million
Serviceable Available Market0 million
Serviceable Obtainable MarketVisionary Founding Team
With extensive experience in business, operations, and healthcare
Seth Bogner
Chairman & CEO
USA, Israel
Hanna Ilesan, PhD
COO
Israel, Ireland
Brian Seidman
Managing Director
Ireland, USA
Medical Leadership
A team of innovators in the field of cardiovascular health
Dr. David Planer
Chief Interventional Cardiologist Hadassah Medical Center, Jerusalem
Israel
Prof. Dr. Paul R. Vogt
Chief of Cardiac Surgery Zurich University Hospital
Switzerland
Prof. Dr. Christian Jux
Head of the Department of Pediatric Cardiology, University Hospital Giessen
Germany
Dr. Gabby Elbaz-Greener
Interventional Cardiologist & Surgeon, Hadassah Medical Center, Jerusalem
Israel
Dr. Glib Iemets
Professor of Pediatric Cardiac Surgery, Director of Ukrainian Children’s Cardiac Center, Kiev
Ukraine
Dr. Robert Kelly
Consultant Cardiologist at Beacon Hospital, Dublin
Ireland
Prof. Dr. Sabine Däbritz
Specialist in Cardiac and thoracic Vascular Surgery, Hirslanden Private Hospital Group, Zurich
Switzerland
Prof. Emeritus Dr. Rolf Jenni
Senior Consultant for Zurich University Hospital, Inventor, Zurich
Switzerland
Contact Us
HeartPoint Global Inc. is a company with offices in US, Ireland and Israel.
Get in touch
Address:
One Alhambra Plaza Coral Gables FL 33134
Phone:
+1 786 320 8038